Adenoviral conjunctivitis Quidel | Rapid Diagnostics | quidel.com | quideleyehealth.com | 800.874.1517 | 858.552.1100 Clinical benefits Identify, isolate and manage contagious patients, preventing spread to other patients and staff. Reduce inappropriate antibiotic use. Offer an accurate, fast, disposable platform that is easy to use. Fast and accurate Results in 10 minutes. 90% sensitivity and 96% specificity. Easy and convenient Disposable test, requires just 4 easy steps. Just sample, dip and read! No additional equipment is needed to administer or interpret. Acute conjunctivitis affects nearly 6.9 million Americans each year. Approximately 50% of cases are misdiagnosed which could result in significant morbidity in patients. 1 Even though viral conjunctivitis is much more commonly seen than bacterial conjunctivitis, 2 at least 60% of conjunctivitis cases are prescribed antibiotics. At Quidel, we believe that kids should not be prescribed antibiotics when they don’t need them. QuickVue Adenoviral conjunctivitis Test is the first rapid, CLIA-waived point-of-care test that detects all known serotypes of adenoviral conjunctivitis. An early and accurate diagnosis may prevent serious complications in the future. With QuickVue Adenoviral conjunctivitis Test you can make a rapid, accurate diagnosis before the patient leaves your office. Rapidly diagnose adenoviral conjunctivitis